首页 > 最新文献

Pediatric Critical Care Medicine最新文献

英文 中文
Early Hemodynamic Support in Resource-Limited Settings: Rethinking Vasoactive Delivery in Pediatric Sepsis. 资源有限环境下的早期血流动力学支持:重新思考儿童败血症的血管活性分娩。
IF 4.5 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2026-02-01 Epub Date: 2025-12-10 DOI: 10.1097/PCC.0000000000003878
Ilana Harwayne-Gidansky
{"title":"Early Hemodynamic Support in Resource-Limited Settings: Rethinking Vasoactive Delivery in Pediatric Sepsis.","authors":"Ilana Harwayne-Gidansky","doi":"10.1097/PCC.0000000000003878","DOIUrl":"10.1097/PCC.0000000000003878","url":null,"abstract":"","PeriodicalId":19760,"journal":{"name":"Pediatric Critical Care Medicine","volume":" ","pages":"225-227"},"PeriodicalIF":4.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145781847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Positive End-Expiratory Pressure on Cardiac Index and Right Ventricular Performance in Ventilated Children Post-Cardiac Surgery. 通气儿童心脏手术后呼气末正压对心脏指数和右心室功能的影响。
IF 4.5 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2026-02-01 Epub Date: 2025-12-19 DOI: 10.1097/PCC.0000000000003880
Jan-Christoph Clausen, Michael Emeis, Richard Hollander, Oliver Miera, Maren Kleine-Brueggeney, Robert G T Blokpoel, Tania Garfias-Veitl, Thomas Asendorf, Vasile-Valentin Vadiunec, Joachim Photiadis, Felix Berger, Martin C J Kneyber

Objective: Lower positive end-expiratory pressure (PEEP) is commonly suggested in congenital heart disease (CHD) patients to prevent hemodynamic impairment and right ventricular (RV) dysfunction. We sought to study the effect of different levels of PEEP on cardiac index, lung mechanics, and RV function in subjects after cardiac surgery.

Design: Prospective, single-center physiology study conducted in a tertiary pediatric cardiac ICU between November 2023 and July 2024.

Setting: Operating room (OR) and cardiac ICU (CICU).

Patients: Subjects younger than 5 years post-cardiac surgery for CHD.

Interventions: Four consecutive PEEP levels: baseline (PEEPstart), high PEEP (baseline plus 4 cm H 2 O; PEEPhigh), low PEEP (baseline minus 4 cm H 2 O; PEEPlow), and return to baseline (PEEPend).

Measurements: In 58 subjects, cardiac index and RV function, static (Cstat) and dynamic compliance, and transpulmonary pressures were measured at each PEEP level and with constant driving pressure. Of these subjects, 81.0% underwent surgery with cardiopulmonary bypass (CPB). The median age was 4.9 months, and 55% of subjects were male. The mean baseline PEEP was 6.2 cm H₂O ( sd 1.4), the mean PEEPhigh was 10.2 cm H₂O ( sd 1.4), and the mean PEEPlow was 3.3 cm H₂O ( sd 0.7).

Main results: Overall, cardiac index and RV performance increased significantly with PEEPhigh ( p < 0.01). Cardiac index decreased in 7 of 58 patients (12%)with PEEPhigh and in 18 of 58 patients (31%) with PEEPlow. Directional change in measures of RV performance and Cstat over time was generally concordant; with manipulation of PEEP, both improved or worsened together, independent of the underlying lesion. Sensitivity analyses showed that the results remained consistent regardless of the location of the measurement (OR vs. CICU), whether inhaled nitric oxide or milrinone was used, whether RV outflow tract obstruction was present, and whether CPB was used.

Conclusions: In children with CHD who underwent biventricular repair, cardiac index, RV function, and Cstat generally improved with higher PEEP, indicating pulmonary recruitment. Changes in cardiac performance and Cstat were closely related, with both improving or worsening together with manipulation of PEEP. This study supports the use of PEEP to optimize lung volume and cardiopulmonary interactions after cardiac surgery.

目的:降低呼气末正压(PEEP)可预防先天性心脏病(CHD)患者血流动力学损害和右心室功能障碍。我们试图研究不同水平的PEEP对心脏手术后心脏指数、肺力学和右心室功能的影响。设计:于2023年11月至2024年7月在一所三级儿科心脏ICU进行前瞻性单中心生理学研究。环境:手术室(OR)和心脏ICU (CICU)。患者:年龄小于5岁的冠心病患者。干预措施:连续四个PEEP水平:基线(PEEPstart)、高PEEP(基线+ 4cm H2O; PEEPhigh)、低PEEP(基线- 4cm H2O; PEEPlow)和返回基线(PEEPend)。测量方法:测量58例受试者在每个PEEP水平和恒定驱动压力下的心脏指数和RV功能、静态顺应性(Cstat)和动态顺应性以及跨肺压力。其中,81.0%的患者接受了体外循环手术(CPB)。中位年龄为4.9个月,55%的受试者为男性。平均基线PEEP为6.2 cm H₂O (sd 1.4),平均PEEPhigh为10.2 cm H₂O (sd 1.4),平均PEEPlow为3.3 cm H₂O (sd 0.7)。主要结果:总体而言,PEEPhigh组心脏指数和右心室功能显著提高(p < 0.01)。58例PEEPhigh患者中有7例(12%)心脏指数下降,58例PEEPlow患者中有18例(31%)心脏指数下降。随着时间的推移,RV性能和Cstat测量的方向性变化大致一致;同时改善或恶化,与潜在病变无关。敏感性分析显示,无论测量位置(OR vs. CICU)、是否使用吸入性一氧化氮或米立酮、是否存在右心室流出道阻塞以及是否使用CPB,结果都保持一致。结论:在接受双心室修复的冠心病患儿中,心脏指数、右室功能和Cstat普遍随着PEEP升高而改善,表明肺功能恢复。心脏功能的改变与Cstat密切相关,与PEEP的操作同时改善或恶化。本研究支持使用PEEP优化心脏手术后肺容量和心肺相互作用。
{"title":"Effect of Positive End-Expiratory Pressure on Cardiac Index and Right Ventricular Performance in Ventilated Children Post-Cardiac Surgery.","authors":"Jan-Christoph Clausen, Michael Emeis, Richard Hollander, Oliver Miera, Maren Kleine-Brueggeney, Robert G T Blokpoel, Tania Garfias-Veitl, Thomas Asendorf, Vasile-Valentin Vadiunec, Joachim Photiadis, Felix Berger, Martin C J Kneyber","doi":"10.1097/PCC.0000000000003880","DOIUrl":"10.1097/PCC.0000000000003880","url":null,"abstract":"<p><strong>Objective: </strong>Lower positive end-expiratory pressure (PEEP) is commonly suggested in congenital heart disease (CHD) patients to prevent hemodynamic impairment and right ventricular (RV) dysfunction. We sought to study the effect of different levels of PEEP on cardiac index, lung mechanics, and RV function in subjects after cardiac surgery.</p><p><strong>Design: </strong>Prospective, single-center physiology study conducted in a tertiary pediatric cardiac ICU between November 2023 and July 2024.</p><p><strong>Setting: </strong>Operating room (OR) and cardiac ICU (CICU).</p><p><strong>Patients: </strong>Subjects younger than 5 years post-cardiac surgery for CHD.</p><p><strong>Interventions: </strong>Four consecutive PEEP levels: baseline (PEEPstart), high PEEP (baseline plus 4 cm H 2 O; PEEPhigh), low PEEP (baseline minus 4 cm H 2 O; PEEPlow), and return to baseline (PEEPend).</p><p><strong>Measurements: </strong>In 58 subjects, cardiac index and RV function, static (Cstat) and dynamic compliance, and transpulmonary pressures were measured at each PEEP level and with constant driving pressure. Of these subjects, 81.0% underwent surgery with cardiopulmonary bypass (CPB). The median age was 4.9 months, and 55% of subjects were male. The mean baseline PEEP was 6.2 cm H₂O ( sd 1.4), the mean PEEPhigh was 10.2 cm H₂O ( sd 1.4), and the mean PEEPlow was 3.3 cm H₂O ( sd 0.7).</p><p><strong>Main results: </strong>Overall, cardiac index and RV performance increased significantly with PEEPhigh ( p < 0.01). Cardiac index decreased in 7 of 58 patients (12%)with PEEPhigh and in 18 of 58 patients (31%) with PEEPlow. Directional change in measures of RV performance and Cstat over time was generally concordant; with manipulation of PEEP, both improved or worsened together, independent of the underlying lesion. Sensitivity analyses showed that the results remained consistent regardless of the location of the measurement (OR vs. CICU), whether inhaled nitric oxide or milrinone was used, whether RV outflow tract obstruction was present, and whether CPB was used.</p><p><strong>Conclusions: </strong>In children with CHD who underwent biventricular repair, cardiac index, RV function, and Cstat generally improved with higher PEEP, indicating pulmonary recruitment. Changes in cardiac performance and Cstat were closely related, with both improving or worsening together with manipulation of PEEP. This study supports the use of PEEP to optimize lung volume and cardiopulmonary interactions after cardiac surgery.</p>","PeriodicalId":19760,"journal":{"name":"Pediatric Critical Care Medicine","volume":" ","pages":"176-186"},"PeriodicalIF":4.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145793782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Child and Parent Outcomes in the 2018-2019 DEPICT (Differences in Access to Emergency Pediatric Intensive Care and Care During Transport) Study: 12-Month Follow-Up Data. 2018-2019年《儿童急诊重症监护和运输过程中护理的差异》研究中的儿童和父母结局:12个月随访数据。
IF 4.5 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2026-02-01 Epub Date: 2025-12-19 DOI: 10.1097/PCC.0000000000003877
Emma C Alexander, Anjalika Mallick, Sarah E Seaton, Ruth Evans, Victoria Barber, Jo Wray, Padmanabhan Ramnarayan

Objective: The 2018-2019 DEPICT (Differences in Access to Emergency pediatric Intensive Care and care during Transport) study in the United Kingdom had a follow-up questionnaire component, 12 months after PICU admission. We now report the quality of life findings in the children and mental health outcomes (i.e., anxiety, depression, and post-traumatic stress disorder [PTSD]) in the parents.

Design: DEPICT cohort follow-up study using questionnaires and registered with ClinicalTrials.gov (NCT03520192) in 2017.

Setting: PICU transport teams and 24 PICUs admitting children transported between January 2018 and January 2019 in United Kingdom.

Patients: DEPICT cohort ( n = 419, depending on missingness) children and related parents/caregivers with 2020 outcome questionnaires.

Interventions: None.

Measurements and main results: We evaluated parental proxy-reported questionnaires covering their child's baseline characteristics, pediatric quality of life (PedsQL) and health utilities index (HUI-2), and healthcare utilization; we also assessed parent questionnaires testing for any anxiety, depression, and PTSD. At the time of transfer, 225 of 419 (53.7%) of the children were aged under 1-year; most required transfer for respiratory reasons; and, 194 of 419 (46.3%) had preexisting comorbidities. At 12-month post-PICU admission, around half of the children with a baseline comorbidity had impaired overall PedsQL quality of life scores (57.1%, 105/184), compared with around a quarter of previously healthy children (23.1%, 49/212). Both PedsQL and HUI-2 scores were significantly worse for children with baseline comorbidities. At follow-up, 105 of 340 (30.9%) of parents met screening thresholds for anxiety, 74 of 340 (21.8%) for depression, and 84 of 298 (28.2%) for PTSD. Parent anxiety, depression and PTSD were correlated with poor quality of life scores for their child.

Conclusions: The 2020, 12-month outcome findings of the 2018-2019 DEPICT study, highlights post-PICU impairments in child quality of life, and high rates of parental mental health issues. Further study of contemporary child and family support, as well as the optimal model for follow-up care, are needed.

目的:英国2018-2019年的儿童急诊重症监护和运输过程中护理的差异研究在PICU入院12个月后进行了随访问卷调查。我们现在报告儿童的生活质量和父母的心理健康结果(即焦虑、抑郁和创伤后应激障碍[PTSD])。设计:采用问卷调查的方式描述队列随访研究,并于2017年在ClinicalTrials.gov (NCT03520192)注册。背景:英国PICU运输团队和24个PICU接收2018年1月至2019年1月期间运送的儿童。患者:用2020年结局问卷描述队列(n = 419,取决于失踪情况)儿童和相关父母/照顾者。干预措施:没有。测量和主要结果:我们评估了父母代理报告的问卷,涵盖了他们孩子的基线特征、儿童生活质量(PedsQL)和健康效用指数(HUI-2),以及医疗保健利用;我们还评估了父母的问卷测试是否存在焦虑、抑郁和创伤后应激障碍。转移时,419例患儿中有225例(53.7%)未满1岁;因呼吸原因最需要转移;419例患者中有194例(46.3%)先前存在合并症。在picu入院后12个月,约有一半的基线合并症儿童的总体PedsQL生活质量评分受损(57.1%,105/184),而约有四分之一的先前健康儿童(23.1%,49/212)。基线合并症患儿的PedsQL和HUI-2评分均明显较差。在随访中,340名家长中有105名(30.9%)符合焦虑筛查阈值,340名家长中有74名(21.8%)符合抑郁筛查阈值,298名家长中有84名(28.2%)符合创伤后应激障碍筛查阈值。父母的焦虑、抑郁和创伤后应激障碍与孩子的生活质量得分较低相关。结论:2018-2019年的描述研究的2020年12个月结果结果突出了picu后儿童生活质量的损害,以及父母心理健康问题的高比例。需要进一步研究当代儿童和家庭的支持,以及最佳的后续护理模式。
{"title":"Child and Parent Outcomes in the 2018-2019 DEPICT (Differences in Access to Emergency Pediatric Intensive Care and Care During Transport) Study: 12-Month Follow-Up Data.","authors":"Emma C Alexander, Anjalika Mallick, Sarah E Seaton, Ruth Evans, Victoria Barber, Jo Wray, Padmanabhan Ramnarayan","doi":"10.1097/PCC.0000000000003877","DOIUrl":"10.1097/PCC.0000000000003877","url":null,"abstract":"<p><strong>Objective: </strong>The 2018-2019 DEPICT (Differences in Access to Emergency pediatric Intensive Care and care during Transport) study in the United Kingdom had a follow-up questionnaire component, 12 months after PICU admission. We now report the quality of life findings in the children and mental health outcomes (i.e., anxiety, depression, and post-traumatic stress disorder [PTSD]) in the parents.</p><p><strong>Design: </strong>DEPICT cohort follow-up study using questionnaires and registered with ClinicalTrials.gov (NCT03520192) in 2017.</p><p><strong>Setting: </strong>PICU transport teams and 24 PICUs admitting children transported between January 2018 and January 2019 in United Kingdom.</p><p><strong>Patients: </strong>DEPICT cohort ( n = 419, depending on missingness) children and related parents/caregivers with 2020 outcome questionnaires.</p><p><strong>Interventions: </strong>None.</p><p><strong>Measurements and main results: </strong>We evaluated parental proxy-reported questionnaires covering their child's baseline characteristics, pediatric quality of life (PedsQL) and health utilities index (HUI-2), and healthcare utilization; we also assessed parent questionnaires testing for any anxiety, depression, and PTSD. At the time of transfer, 225 of 419 (53.7%) of the children were aged under 1-year; most required transfer for respiratory reasons; and, 194 of 419 (46.3%) had preexisting comorbidities. At 12-month post-PICU admission, around half of the children with a baseline comorbidity had impaired overall PedsQL quality of life scores (57.1%, 105/184), compared with around a quarter of previously healthy children (23.1%, 49/212). Both PedsQL and HUI-2 scores were significantly worse for children with baseline comorbidities. At follow-up, 105 of 340 (30.9%) of parents met screening thresholds for anxiety, 74 of 340 (21.8%) for depression, and 84 of 298 (28.2%) for PTSD. Parent anxiety, depression and PTSD were correlated with poor quality of life scores for their child.</p><p><strong>Conclusions: </strong>The 2020, 12-month outcome findings of the 2018-2019 DEPICT study, highlights post-PICU impairments in child quality of life, and high rates of parental mental health issues. Further study of contemporary child and family support, as well as the optimal model for follow-up care, are needed.</p>","PeriodicalId":19760,"journal":{"name":"Pediatric Critical Care Medicine","volume":" ","pages":"166-175"},"PeriodicalIF":4.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145794601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Airway, Breathing, Circulation-Plan, Risk, Options (ABC-PRO) Handover Tool in the PICU: Retrospective Evaluation of Pre- Versus Post-Implementation and Occurrence Rate of Cardiac Arrests, 2020-2023. PICU中的气道、呼吸、循环计划、风险、选项(ABC-PRO)切换工具:实施前后和心脏骤停发生率的回顾性评估,2020-2023。
IF 4.5 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2026-02-01 Epub Date: 2025-12-24 DOI: 10.1097/PCC.0000000000003884
Martina De Gaudenzi, Rebeca Mozun, Luregn J Schlapbach, Janet F Kelly-Geyer

Objectives: Healthcare improvement studies indicate a potential to reduce cardiac arrests in the PICU through anticipatory care and shared awareness. We developed a structured risk-assessment and anticipation tool (i.e., the Airway, Breathing, Circulation-Plan, Risk, Options [ABC-PRO]) for PICU patient handover and assessed the impact on cardiac arrest occurrence rate.

Design: Single-center, retrospective healthcare improvement audit of before- vs. after-ABC-PRO tool implementation.

Setting: Multidisciplinary, 25-bed PICU of the University Children's Hospital, Zurich.

Patients: Patients younger than 18 years admitted to the PICU (from January 2020 to September 2023) whose parents/guardians had not refused consent for general use of personal PICU administrative data.

Interventions: We implemented the ABC-PRO handover tool and the primary outcome was the occurrence rate of cardiac arrests necessitating cardiopulmonary resuscitation, before vs. after the implementation. Cardiac arrest incidence was calculated per 1000 PICU-days using Poisson regressions, adjusted for age, sex, and Pediatric Index of Mortality.

Measurements and main results: During 4,370 PICU admissions (21,804 PICU-days), there were 63 cardiac arrests in 59 patients. Of these, 43 occurred pre- (12,911 PICU-days), and eight post-implementation (6,156 PICU-days). The adjusted cardiac arrest occurrence rate pre- vs. post-implementation was 2.9 vs. 1.2 per 1000 PICU-days with an adjusted rate ratio (aRR, 0.42; 95% CI, 0.20-0.88) overall, 0.47 (95% CI, 0.20-1.1) among cardiac, and 0.48 (95% CI, 0.14-1.6) among noncardiac patients. Cardiac arrests decreased most in cardiac surgical patients (aRR, 0.23 [95% CI, 0.06-0.96]). However, we failed to identify a difference in cardiac arrest mortality pre- vs. post-implementation (17/41 vs. 1/8; mean percentage difference, 29%; 95% CI, 2-56%; p = 0.12).

Conclusions: The ABC-PRO PICU handover tool provides a structured approach to risk-assessment and anticipation and may be associated with a decreased cardiac arrest occurrence rate in the PICU, with effects most pronounced in cardiac surgical patients.

目的:医疗保健改善研究表明,通过预期护理和共同意识,有可能减少PICU内心脏骤停。我们开发了一种结构化的PICU患者移交风险评估和预测工具(即气道,呼吸,循环-计划,风险,选项[ABC-PRO]),并评估了对心脏骤停发生率的影响。设计:对abc - pro工具实施前后的单中心、回顾性医疗保健改进审核。环境:苏黎世大学儿童医院的多学科、25个床位的PICU。患者:PICU收治的年龄小于18岁的患者(2020年1月至2023年9月),其父母/监护人未拒绝一般使用PICU个人管理数据。干预措施:我们实施了ABC-PRO切换工具,主要结果是实施前和实施后需要心肺复苏的心脏骤停发生率。使用泊松回归计算每1000 PICU-days的心脏骤停发生率,并根据年龄、性别和儿科死亡率指数进行调整。测量结果和主要结果:在4370例PICU入院期间(21804 PICU-days), 59例患者发生63例心脏骤停。其中43例发生在实施前(12,911 PICU-days), 8例发生在实施后(6,156 PICU-days)。实施前和实施后的调整心脏骤停发生率分别为2.9和1.2 / 1000 PICU-days,总体调整率比(aRR, 0.42; 95% CI, 0.20-0.88),心脏患者为0.47 (95% CI, 0.20-1.1),非心脏患者为0.48 (95% CI, 0.14-1.6)。心脏手术患者心脏骤停减少最多(aRR, 0.23 [95% CI, 0.06-0.96])。然而,我们未能确定实施前与实施后心脏骤停死亡率的差异(17/41 vs 1/8;平均百分比差异为29%;95% CI, 2-56%; p = 0.12)。结论:ABC-PRO PICU切换工具提供了一种结构化的风险评估和预测方法,可能与PICU中心脏骤停发生率的降低有关,其效果在心脏手术患者中最为明显。
{"title":"The Airway, Breathing, Circulation-Plan, Risk, Options (ABC-PRO) Handover Tool in the PICU: Retrospective Evaluation of Pre- Versus Post-Implementation and Occurrence Rate of Cardiac Arrests, 2020-2023.","authors":"Martina De Gaudenzi, Rebeca Mozun, Luregn J Schlapbach, Janet F Kelly-Geyer","doi":"10.1097/PCC.0000000000003884","DOIUrl":"10.1097/PCC.0000000000003884","url":null,"abstract":"<p><strong>Objectives: </strong>Healthcare improvement studies indicate a potential to reduce cardiac arrests in the PICU through anticipatory care and shared awareness. We developed a structured risk-assessment and anticipation tool (i.e., the Airway, Breathing, Circulation-Plan, Risk, Options [ABC-PRO]) for PICU patient handover and assessed the impact on cardiac arrest occurrence rate.</p><p><strong>Design: </strong>Single-center, retrospective healthcare improvement audit of before- vs. after-ABC-PRO tool implementation.</p><p><strong>Setting: </strong>Multidisciplinary, 25-bed PICU of the University Children's Hospital, Zurich.</p><p><strong>Patients: </strong>Patients younger than 18 years admitted to the PICU (from January 2020 to September 2023) whose parents/guardians had not refused consent for general use of personal PICU administrative data.</p><p><strong>Interventions: </strong>We implemented the ABC-PRO handover tool and the primary outcome was the occurrence rate of cardiac arrests necessitating cardiopulmonary resuscitation, before vs. after the implementation. Cardiac arrest incidence was calculated per 1000 PICU-days using Poisson regressions, adjusted for age, sex, and Pediatric Index of Mortality.</p><p><strong>Measurements and main results: </strong>During 4,370 PICU admissions (21,804 PICU-days), there were 63 cardiac arrests in 59 patients. Of these, 43 occurred pre- (12,911 PICU-days), and eight post-implementation (6,156 PICU-days). The adjusted cardiac arrest occurrence rate pre- vs. post-implementation was 2.9 vs. 1.2 per 1000 PICU-days with an adjusted rate ratio (aRR, 0.42; 95% CI, 0.20-0.88) overall, 0.47 (95% CI, 0.20-1.1) among cardiac, and 0.48 (95% CI, 0.14-1.6) among noncardiac patients. Cardiac arrests decreased most in cardiac surgical patients (aRR, 0.23 [95% CI, 0.06-0.96]). However, we failed to identify a difference in cardiac arrest mortality pre- vs. post-implementation (17/41 vs. 1/8; mean percentage difference, 29%; 95% CI, 2-56%; p = 0.12).</p><p><strong>Conclusions: </strong>The ABC-PRO PICU handover tool provides a structured approach to risk-assessment and anticipation and may be associated with a decreased cardiac arrest occurrence rate in the PICU, with effects most pronounced in cardiac surgical patients.</p>","PeriodicalId":19760,"journal":{"name":"Pediatric Critical Care Medicine","volume":" ","pages":"197-206"},"PeriodicalIF":4.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12834262/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145820143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Withdrawal of Life-Sustaining Treatment in Children Managed in Nine PICUs in the United States: A Secondary Analysis of the Death One Hour After Terminal Extubation (DONATE) Dataset, 2009-2021. 美国9个picu中儿童停止生命维持治疗:对终端拔管后1小时死亡的二次分析(DONATE)数据集,2009-2021
IF 4.5 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2026-02-01 Epub Date: 2025-12-17 DOI: 10.1097/PCC.0000000000003879
Sareen S Shah, Eugene Laksana, Melissa D Aczon, Michael Avesar, Kimberly Burkiewicz, Harsha K Chandnani, Nina A Fainberg, Stephanie C Hsu, Michael C McCrory, Katie R Hodge, Charlene P Pringle, Patrick A Ross, Jui K Shah, Linda B Siegel, Sandeep Tripathi, Wynne E Morrison, Randall C Wetzel, Meredith C Winter

Objectives: To describe medical management surrounding withdrawal of life-sustaining therapy (WLST) in nine U.S. PICUs.

Design: Retrospective, secondary analysis of the "Death One Hour After Terminal Extubation" (DONATE) cohort (2009-2021) assessing usage patterns of: 1) analgesics and sedatives; 2) vasoactive infusions; 3) neuromuscular blockade; and 4) post-extubation respiratory support.

Setting: Nine U.S. PICUs.

Patients: Children and adolescents 0-21 years old, who had died after WLST (discontinuation of invasive mechanical ventilation).

Interventions: None.

Measurements and main results: Of 905 patients, 680 (75.1%) died within 1 hour of WLST. Opioids were administered in 721 of 905 patients (79.7%); across sites the range was 68-89% ( p < 0.001). We did not observe a temporal trend. Benzodiazepines were used in 507 of 905 patients (56.0%; site range, 41-66%; p < 0.001), with lower odds of usage per year (odds ratio [OR], 0.95 per year; 95% CI, 0.90-0.99 per year; p = 0.04). Dexmedetomidine was used in 140 of 905 patients (15.5%; sites range, 4-21%; p = 0.002), with greater odds of usage per year (OR, 1.16 per year; 95% CI, 1.05-1.27 per year; p = 0.004). Vasoactive infusions were discontinued in 458 of 520 patients (88.1%) receiving this medication (site range, 59-100%; p < 0.001), with greater odds of discontinuation per year (OR, 1.15 per year; 95% CI, 1.04-1.26 per year; p = 0.007). Neuromuscular blockade was used in 46 of 905 patients (5.1%; sites range, 0-13%; p < 0.001), with greater odds of usage per year (OR, 1.23 per year; 95% CI, 1.08-1.40 per year; p = 0.002). Use of any post-extubation respiratory support occurred in 50 of 905 patients (5.5%), and we did not identify an association with site or year-on-year trend.

Conclusions: The 2009-2021 DONATE dataset shows substantial institutional and temporal variability in WLST practices across our nine collaborating PICUs in the United States. Future studies should focus on understanding the drivers of variability to improve the consistency and quality of end-of-life management.

目的:描述美国9例picu患者停止生命维持治疗(WLST)的医疗管理。设计:对2009-2021年“终末拔管后1小时死亡”(DONATE)队列进行回顾性、二次分析,评估使用模式:1)镇痛药和镇静剂;2)血管活性输注;3)神经肌肉阻滞;4)拔管后呼吸支持。设置:9个美国picu。患者:0-21岁的儿童和青少年,在WLST(停止有创机械通气)后死亡。干预措施:没有。测量和主要结果:905例患者中,680例(75.1%)在WLST 1小时内死亡。905例患者中有721例(79.7%)使用阿片类药物;各部位的差异为68% -89% (p < 0.001)。我们没有观察到时间趋势。905例患者中有507例使用苯二氮卓类药物(56.0%;部位范围,41-66%;p < 0.001),每年使用的几率较低(比值比[OR], 0.95 /年;95% CI, 0.90-0.99 /年;p = 0.04)。905例患者中有140例使用右美托咪定(15.5%;地点范围,4-21%;p = 0.002),每年使用的几率更高(OR, 1.16 /年;95% CI, 1.05-1.27 /年;p = 0.004)。接受该药物治疗的520例患者中,有458例(88.1%)停止了血管活性输注(部位范围,59-100%;p < 0.001),每年停止输注的几率更高(OR, 1.15 /年;95% CI, 1.04-1.26 /年;p = 0.007)。905例患者中有46例(5.1%;部位范围0-13%;p < 0.001)使用神经肌肉阻断剂,每年使用的几率更高(OR, 1.23 /年;95% CI, 1.08-1.40 /年;p = 0.002)。905例患者中有50例(5.5%)使用拔管后呼吸支持,我们没有发现与部位或年度趋势的关联。结论:2009-2021年的DONATE数据集显示了我们在美国9个合作picu中WLST实践的实质性制度和时间变化。未来的研究应集中在了解可变性的驱动因素,以提高生命末期管理的一致性和质量。
{"title":"Withdrawal of Life-Sustaining Treatment in Children Managed in Nine PICUs in the United States: A Secondary Analysis of the Death One Hour After Terminal Extubation (DONATE) Dataset, 2009-2021.","authors":"Sareen S Shah, Eugene Laksana, Melissa D Aczon, Michael Avesar, Kimberly Burkiewicz, Harsha K Chandnani, Nina A Fainberg, Stephanie C Hsu, Michael C McCrory, Katie R Hodge, Charlene P Pringle, Patrick A Ross, Jui K Shah, Linda B Siegel, Sandeep Tripathi, Wynne E Morrison, Randall C Wetzel, Meredith C Winter","doi":"10.1097/PCC.0000000000003879","DOIUrl":"10.1097/PCC.0000000000003879","url":null,"abstract":"<p><strong>Objectives: </strong>To describe medical management surrounding withdrawal of life-sustaining therapy (WLST) in nine U.S. PICUs.</p><p><strong>Design: </strong>Retrospective, secondary analysis of the \"Death One Hour After Terminal Extubation\" (DONATE) cohort (2009-2021) assessing usage patterns of: 1) analgesics and sedatives; 2) vasoactive infusions; 3) neuromuscular blockade; and 4) post-extubation respiratory support.</p><p><strong>Setting: </strong>Nine U.S. PICUs.</p><p><strong>Patients: </strong>Children and adolescents 0-21 years old, who had died after WLST (discontinuation of invasive mechanical ventilation).</p><p><strong>Interventions: </strong>None.</p><p><strong>Measurements and main results: </strong>Of 905 patients, 680 (75.1%) died within 1 hour of WLST. Opioids were administered in 721 of 905 patients (79.7%); across sites the range was 68-89% ( p < 0.001). We did not observe a temporal trend. Benzodiazepines were used in 507 of 905 patients (56.0%; site range, 41-66%; p < 0.001), with lower odds of usage per year (odds ratio [OR], 0.95 per year; 95% CI, 0.90-0.99 per year; p = 0.04). Dexmedetomidine was used in 140 of 905 patients (15.5%; sites range, 4-21%; p = 0.002), with greater odds of usage per year (OR, 1.16 per year; 95% CI, 1.05-1.27 per year; p = 0.004). Vasoactive infusions were discontinued in 458 of 520 patients (88.1%) receiving this medication (site range, 59-100%; p < 0.001), with greater odds of discontinuation per year (OR, 1.15 per year; 95% CI, 1.04-1.26 per year; p = 0.007). Neuromuscular blockade was used in 46 of 905 patients (5.1%; sites range, 0-13%; p < 0.001), with greater odds of usage per year (OR, 1.23 per year; 95% CI, 1.08-1.40 per year; p = 0.002). Use of any post-extubation respiratory support occurred in 50 of 905 patients (5.5%), and we did not identify an association with site or year-on-year trend.</p><p><strong>Conclusions: </strong>The 2009-2021 DONATE dataset shows substantial institutional and temporal variability in WLST practices across our nine collaborating PICUs in the United States. Future studies should focus on understanding the drivers of variability to improve the consistency and quality of end-of-life management.</p>","PeriodicalId":19760,"journal":{"name":"Pediatric Critical Care Medicine","volume":" ","pages":"146-154"},"PeriodicalIF":4.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145768903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reducing Acute Kidney Injury in Critically Ill Pediatric Patients: Quality Improvement Project Targeting Nephrotoxic Medication Exposures. 减少危重儿科患者的急性肾损伤:针对肾毒性药物暴露的质量改进项目。
IF 4.5 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2026-02-01 Epub Date: 2025-12-30 DOI: 10.1097/PCC.0000000000003883
Natalie Capretta, Diana Zepeda-Orozco, W Joshua Frazier, Jeffrey Lutmer, Cheryl Lieb-Sargel, Jennifer A Muszynski, Lindsay Kalata, Michael Welty, Ashlee Leone, Robert J Gajarski

Objective: To reduce acute kidney injury (AKI) associated with nephrotoxic medication (NTM) exposure in critically ill pediatric patients through a structured quality improvement (QI) initiative.

Design: Prospective, multi-phased QI project.

Setting: A single-center, free-standing, quaternary care children's hospital.

Patients: All patients admitted to the PICU during the study period.

Interventions: A three-phase intervention strategy was implemented to increase awareness surrounding NTM exposures in PICU and their role in subsequent AKI development. Phase 1 introduced monthly pharmacist-led educational session for resident physicians. Phase 2 incorporated an informational handout reviewed during monthly resident orientations. In phase 3, clinical pharmacists provided daily notifications to attending physicians for patients meeting NTM exposure criteria, offering timely alternatives and AKI monitoring recommendations.

Measurements and main results: NTM exposure and NTM-associated AKI (NAKI) rates per 1000 patient-days were measured across pre-intervention and post-intervention periods. From May 1, 2021, to December 31, 2023, a total of 34,631 patient-days were included. During this period, 2410 and 388 patient-days, respectively, satisfied NTM exposure and NAKI criteria. This accounted for 1039 NTM exposure events in 742 patients and 159 NAKI episodes in 125 unique patients. Following interventions, NTM exposure rates declined from 30.6 to 26.9 per 1000 patient-days (a 12.4% reduction), and NAKI rates decreased from 5.6 to 2.5 per 1000 patient-days (a 55% reduction).

Conclusions: Targeted PICU-specific interventions, including routine stakeholder education and pharmacy-driven daily provider notifications, were associated with reductions in NTM exposure and subsequent NAKI rates in critically ill patients. Efforts to integrate and sustain these strategies at the institutional level are currently in progress.

目的:通过结构化质量改善(QI)计划减少危重儿科患者肾毒性药物(NTM)暴露相关的急性肾损伤(AKI)。设计:前瞻性、多阶段的QI项目。环境:单中心、独立、四级护理儿童医院。患者:所有在研究期间入住PICU的患者。干预措施:实施了三阶段干预策略,以提高对PICU中NTM暴露及其在随后AKI发展中的作用的认识。第一阶段为住院医师引入每月药剂师主导的教育课程。第二阶段在每月的居民培训中纳入了一份信息讲义。在第三阶段,临床药师每天向主治医师通报符合NTM暴露标准的患者,及时提供替代方案和AKI监测建议。测量结果和主要结果:在干预前和干预后测量了每1000患者日的NTM暴露和NTM相关AKI (NAKI)率。从2021年5月1日至2023年12月31日,共纳入34,631个患者日。在此期间,分别有2410和388患者日满足NTM暴露和NAKI标准。其中742例患者中有1039例NTM暴露事件,125例患者中有159例NAKI发作。干预后,NTM暴露率从每1000患者日30.6降至26.9(减少12.4%),NAKI发生率从每1000患者日5.6降至2.5(减少55%)。结论:有针对性的picu特定干预措施,包括常规利益相关者教育和药房驱动的每日提供者通知,与危重患者NTM暴露和随后的NAKI发生率的降低有关。目前正在努力在机构一级整合和维持这些战略。
{"title":"Reducing Acute Kidney Injury in Critically Ill Pediatric Patients: Quality Improvement Project Targeting Nephrotoxic Medication Exposures.","authors":"Natalie Capretta, Diana Zepeda-Orozco, W Joshua Frazier, Jeffrey Lutmer, Cheryl Lieb-Sargel, Jennifer A Muszynski, Lindsay Kalata, Michael Welty, Ashlee Leone, Robert J Gajarski","doi":"10.1097/PCC.0000000000003883","DOIUrl":"10.1097/PCC.0000000000003883","url":null,"abstract":"<p><strong>Objective: </strong>To reduce acute kidney injury (AKI) associated with nephrotoxic medication (NTM) exposure in critically ill pediatric patients through a structured quality improvement (QI) initiative.</p><p><strong>Design: </strong>Prospective, multi-phased QI project.</p><p><strong>Setting: </strong>A single-center, free-standing, quaternary care children's hospital.</p><p><strong>Patients: </strong>All patients admitted to the PICU during the study period.</p><p><strong>Interventions: </strong>A three-phase intervention strategy was implemented to increase awareness surrounding NTM exposures in PICU and their role in subsequent AKI development. Phase 1 introduced monthly pharmacist-led educational session for resident physicians. Phase 2 incorporated an informational handout reviewed during monthly resident orientations. In phase 3, clinical pharmacists provided daily notifications to attending physicians for patients meeting NTM exposure criteria, offering timely alternatives and AKI monitoring recommendations.</p><p><strong>Measurements and main results: </strong>NTM exposure and NTM-associated AKI (NAKI) rates per 1000 patient-days were measured across pre-intervention and post-intervention periods. From May 1, 2021, to December 31, 2023, a total of 34,631 patient-days were included. During this period, 2410 and 388 patient-days, respectively, satisfied NTM exposure and NAKI criteria. This accounted for 1039 NTM exposure events in 742 patients and 159 NAKI episodes in 125 unique patients. Following interventions, NTM exposure rates declined from 30.6 to 26.9 per 1000 patient-days (a 12.4% reduction), and NAKI rates decreased from 5.6 to 2.5 per 1000 patient-days (a 55% reduction).</p><p><strong>Conclusions: </strong>Targeted PICU-specific interventions, including routine stakeholder education and pharmacy-driven daily provider notifications, were associated with reductions in NTM exposure and subsequent NAKI rates in critically ill patients. Efforts to integrate and sustain these strategies at the institutional level are currently in progress.</p>","PeriodicalId":19760,"journal":{"name":"Pediatric Critical Care Medicine","volume":" ","pages":"187-196"},"PeriodicalIF":4.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Good Practice Concepts in Pediatric Critical Care Point-of-Care Ultrasound: A Modified Delphi Consensus Initiative. 儿科危重护理点超声的良好实践概念:改进的德尔菲共识倡议。
IF 4.5 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2026-02-01 Epub Date: 2026-02-05 DOI: 10.1097/PCC.0000000000003881
Jamie S Penk, Vidit Bhargava, Harsha Chandnani, Grace Chong, Thomas Conlon, Ryan L DeSanti, J Wesley Diddle, Alejandro Floh, Saul Flores, Anyir Hsieh, David Kantor, Daniel Kaplan, Benjamin Kozyak, Boran Li, Christopher Lumpkin, Jennifer MacDonald, Ivanna Maxson, Akira Nishisaki, Meghna D Patel, Becky J Riggs, Michael Lintner Rivera, Michael Martinez, Marcos Mills, Michelle Ramírez, Sandeep Tripathi, Ahmed Veten, Niranjan Vijayakumar, Jesse Wenger, David K Werho, Erik Su, Awni Al-Subu

Objective: We assembled a workgroup within the Pediatric Research Collaborative on Critical UltraSound (PeRCCUS), a subgroup of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI), to define early guidance for point-of-care ultrasound (POCUS) institutional practice and foster future comprehensive guidelines for its broad adoption in pediatric critical care medicine.

Design: A modified Delphi method was used for creating the statements. The first meeting was an open proposal session for workgroup members to suggest items for consideration. This was followed by a cycle of voting for levels of agreement along a 7-point Likert-type scale. Items were reviewed, with only items receiving a score of greater than or equal to 6 progressing to the next stage of voting and lower-scoring items reconsidered, with only consensus items proceeding to the next stage for additional rounds of voting until consensus was reached.

Setting: Multi-institutional, multidisciplinary, workgroup of experts on POCUS organized within PeRCCUS as a subgroup of PALISI.

Interventions: None.

Measurements and main results: Consensus was obtained for 25 recommendations across five domains: clinical application, quality assurance, equipment, education, and research.

Conclusions: We report consensus recommendations for institutions on clinical use, educational programs, quality assurance, technical requirements, and future research opportunities for the adoption of pediatric critical care medicine POCUS.

目的:我们在儿科重症超声研究合作组织(PeRCCUS)内组建了一个工作组,该工作组是儿科急性肺损伤和脓毒症研究人员(PALISI)的一个亚组,旨在为护理点超声(POCUS)的机构实践制定早期指南,并促进其在儿科重症医学中广泛采用的未来综合指南。设计:采用改进的德尔菲法创建语句。第一次会议是公开提案会议,供工作组成员提出供审议的项目。接下来是按照李克特7分制对同意程度进行一轮投票。对项目进行审查,只有得分大于或等于6分的项目进入下一阶段投票,得分较低的项目重新审议,只有协商一致的项目进入下一阶段进行额外的投票,直到达成协商一致意见为止。环境:作为PALISI的一个子小组,PeRCCUS内组织的多机构,多学科,POCUS专家工作组。干预措施:没有。测量结果和主要结果:在临床应用、质量保证、设备、教育和研究五个领域获得了25项建议的共识。结论:我们报告了在临床使用、教育计划、质量保证、技术要求和未来研究机会方面对机构采用儿科重症医学POCUS的共识建议。
{"title":"Good Practice Concepts in Pediatric Critical Care Point-of-Care Ultrasound: A Modified Delphi Consensus Initiative.","authors":"Jamie S Penk, Vidit Bhargava, Harsha Chandnani, Grace Chong, Thomas Conlon, Ryan L DeSanti, J Wesley Diddle, Alejandro Floh, Saul Flores, Anyir Hsieh, David Kantor, Daniel Kaplan, Benjamin Kozyak, Boran Li, Christopher Lumpkin, Jennifer MacDonald, Ivanna Maxson, Akira Nishisaki, Meghna D Patel, Becky J Riggs, Michael Lintner Rivera, Michael Martinez, Marcos Mills, Michelle Ramírez, Sandeep Tripathi, Ahmed Veten, Niranjan Vijayakumar, Jesse Wenger, David K Werho, Erik Su, Awni Al-Subu","doi":"10.1097/PCC.0000000000003881","DOIUrl":"https://doi.org/10.1097/PCC.0000000000003881","url":null,"abstract":"<p><strong>Objective: </strong>We assembled a workgroup within the Pediatric Research Collaborative on Critical UltraSound (PeRCCUS), a subgroup of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI), to define early guidance for point-of-care ultrasound (POCUS) institutional practice and foster future comprehensive guidelines for its broad adoption in pediatric critical care medicine.</p><p><strong>Design: </strong>A modified Delphi method was used for creating the statements. The first meeting was an open proposal session for workgroup members to suggest items for consideration. This was followed by a cycle of voting for levels of agreement along a 7-point Likert-type scale. Items were reviewed, with only items receiving a score of greater than or equal to 6 progressing to the next stage of voting and lower-scoring items reconsidered, with only consensus items proceeding to the next stage for additional rounds of voting until consensus was reached.</p><p><strong>Setting: </strong>Multi-institutional, multidisciplinary, workgroup of experts on POCUS organized within PeRCCUS as a subgroup of PALISI.</p><p><strong>Interventions: </strong>None.</p><p><strong>Measurements and main results: </strong>Consensus was obtained for 25 recommendations across five domains: clinical application, quality assurance, equipment, education, and research.</p><p><strong>Conclusions: </strong>We report consensus recommendations for institutions on clinical use, educational programs, quality assurance, technical requirements, and future research opportunities for the adoption of pediatric critical care medicine POCUS.</p>","PeriodicalId":19760,"journal":{"name":"Pediatric Critical Care Medicine","volume":"27 2","pages":"228-234"},"PeriodicalIF":4.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146125912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Follow-Up Brain MRI After Carotid Reconstruction or Ligation in Neonatal Venoarterial Extracorporeal Membrane Oxygenation: Single-Center Retrospective Cohort, 2009-2022. 新生儿静脉动脉体外膜氧合颈动脉重建或结扎后的随访脑MRI:单中心回顾性队列,2009-2022。
IF 4.5 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2026-02-01 Epub Date: 2025-11-27 DOI: 10.1097/PCC.0000000000003866
Shunpei Okochi, Alexander Kreger, Isha Atre, Nahmah Kim-Campbell, Paul Waltz, Subramanian Subramanian, Burhan Mahmood, Joseph T Church

Objectives: In neonates, the carotid artery can be ligated or reconstructed at the time of decannulation from venoarterial extracorporeal membrane oxygenation (VA-ECMO). However, there is a paucity of data on the neurologic outcomes of one approach vs. the other. We therefore aimed to compare the brain MRI of VA-ECMO patients who had either undergone carotid reconstruction or ligation at the time of decannulation in our NICU.

Design: Single-center retrospective study.

Setting: Tertiary-level neonatal care, that is, level IV NICU.

Patients: Neonates younger than 28 days old who survived to VA-ECMO decannulation and underwent routine post-decannulation brain MRI between June 2009 and September 2022.

Interventions: None.

Measurements and main results: Eighty-one patients were included in this study: 38 of 81 (47%) with carotid reconstruction and 43 of 81 (53%) who underwent carotid ligation. We failed to identify associations between decannulation strategy and demographics, ECMO indication, cannulation duration, head ultrasound abnormalities during ECMO, and survival to hospital discharge. Overall, 54 of 81 patients (67%) displayed at least one abnormality on post-decannulation brain MRI. We failed to identify an association between decannulation strategy and focal ischemic lesions, MRI injury score, and proportion with intraventricular hemorrhage. However, there was an association between strategy and grade 2-4 IVH (reconstruction vs. ligation: 10 of 38 vs. 3 of 43; mean difference 19.3% [95% CI, 3.1-35.6%], p = 0.02).

Conclusions: In our neonatal VA-ECMO series from 2009 to 2022, follow-up brain MRI shows a high frequency of abnormalities or lesions. Overall, we failed to identify an association between decannulation strategy (i.e., carotid ligation or reconstruction) and proportion with ischemic findings. However, there appears to be an association between carotid reconstruction and higher-grade IVH. Further studies are needed to help with decision-making at the time of decannulation, to discern the mechanisms underlying the radiographic differences we identified in our series, and to investigate the connection between structural changes and long-term neurocognitive outcomes.

目的:在新生儿颈动脉体外膜氧合(VA-ECMO)脱管时,可以结扎或重建颈动脉。然而,关于一种方法与另一种方法的神经学结果的数据缺乏。因此,我们的目的是比较在我们的NICU进行颈动脉重建或结扎手术时VA-ECMO患者的脑MRI。设计:单中心回顾性研究。环境:三级新生儿护理,即IV级NICU。患者:在2009年6月至2022年9月期间,存活至VA-ECMO脱管并接受常规脱管后脑MRI的小于28天的新生儿。干预措施:没有。测量和主要结果:81例患者纳入本研究:81例患者中有38例(47%)行颈动脉重建,43例(53%)行颈动脉结扎。我们未能确定脱管策略与人口统计学、ECMO指征、插管时间、ECMO期间头部超声异常以及存活至出院之间的关系。总体而言,81例患者中有54例(67%)在脱管后的脑MRI上表现出至少一种异常。我们未能确定脱管策略与局灶性缺血性病变、MRI损伤评分和脑室内出血比例之间的关联。然而,策略与2-4级IVH之间存在关联(重建与结扎:38人中有10人对43人中有3人;平均差异为19.3% [95% CI, 3.1-35.6%], p = 0.02)。结论:在我们2009年至2022年的新生儿VA-ECMO系列中,随访的脑MRI显示异常或病变的频率很高。总的来说,我们未能确定脱管策略(即颈动脉结扎或重建)与缺血性发现的比例之间的关联。然而,颈动脉重建与高级别IVH之间似乎存在关联。我们还需要进一步的研究来帮助患者在进行脱管手术时做出决策,辨别我们在本系列研究中发现的放射学差异背后的机制,并调查结构变化与长期神经认知结果之间的联系。
{"title":"Follow-Up Brain MRI After Carotid Reconstruction or Ligation in Neonatal Venoarterial Extracorporeal Membrane Oxygenation: Single-Center Retrospective Cohort, 2009-2022.","authors":"Shunpei Okochi, Alexander Kreger, Isha Atre, Nahmah Kim-Campbell, Paul Waltz, Subramanian Subramanian, Burhan Mahmood, Joseph T Church","doi":"10.1097/PCC.0000000000003866","DOIUrl":"10.1097/PCC.0000000000003866","url":null,"abstract":"<p><strong>Objectives: </strong>In neonates, the carotid artery can be ligated or reconstructed at the time of decannulation from venoarterial extracorporeal membrane oxygenation (VA-ECMO). However, there is a paucity of data on the neurologic outcomes of one approach vs. the other. We therefore aimed to compare the brain MRI of VA-ECMO patients who had either undergone carotid reconstruction or ligation at the time of decannulation in our NICU.</p><p><strong>Design: </strong>Single-center retrospective study.</p><p><strong>Setting: </strong>Tertiary-level neonatal care, that is, level IV NICU.</p><p><strong>Patients: </strong>Neonates younger than 28 days old who survived to VA-ECMO decannulation and underwent routine post-decannulation brain MRI between June 2009 and September 2022.</p><p><strong>Interventions: </strong>None.</p><p><strong>Measurements and main results: </strong>Eighty-one patients were included in this study: 38 of 81 (47%) with carotid reconstruction and 43 of 81 (53%) who underwent carotid ligation. We failed to identify associations between decannulation strategy and demographics, ECMO indication, cannulation duration, head ultrasound abnormalities during ECMO, and survival to hospital discharge. Overall, 54 of 81 patients (67%) displayed at least one abnormality on post-decannulation brain MRI. We failed to identify an association between decannulation strategy and focal ischemic lesions, MRI injury score, and proportion with intraventricular hemorrhage. However, there was an association between strategy and grade 2-4 IVH (reconstruction vs. ligation: 10 of 38 vs. 3 of 43; mean difference 19.3% [95% CI, 3.1-35.6%], p = 0.02).</p><p><strong>Conclusions: </strong>In our neonatal VA-ECMO series from 2009 to 2022, follow-up brain MRI shows a high frequency of abnormalities or lesions. Overall, we failed to identify an association between decannulation strategy (i.e., carotid ligation or reconstruction) and proportion with ischemic findings. However, there appears to be an association between carotid reconstruction and higher-grade IVH. Further studies are needed to help with decision-making at the time of decannulation, to discern the mechanisms underlying the radiographic differences we identified in our series, and to investigate the connection between structural changes and long-term neurocognitive outcomes.</p>","PeriodicalId":19760,"journal":{"name":"Pediatric Critical Care Medicine","volume":" ","pages":"126-136"},"PeriodicalIF":4.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145637168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using Point-of-Care Ultrasound in the PICU: What We Now Know and What We Want to Know? 在PICU中使用即时超声:我们现在知道什么,我们想知道什么?
IF 4.5 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2026-02-01 Epub Date: 2026-02-05 DOI: 10.1097/PCC.0000000000003898
Robert C Tasker
{"title":"Using Point-of-Care Ultrasound in the PICU: What We Now Know and What We Want to Know?","authors":"Robert C Tasker","doi":"10.1097/PCC.0000000000003898","DOIUrl":"https://doi.org/10.1097/PCC.0000000000003898","url":null,"abstract":"","PeriodicalId":19760,"journal":{"name":"Pediatric Critical Care Medicine","volume":"27 2","pages":"218-221"},"PeriodicalIF":4.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146126016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sepsis Bundle Adherence and Early Vasopressor Administration in Pediatric Septic Shock: Secondary Analysis of Outcomes in a 2023 Multicenter Cohort in Bolivia. 脓毒症Bundle依从性和早期给药:玻利维亚2023年多中心队列结果的二次分析
IF 4.5 2区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2026-02-01 Epub Date: 2025-12-04 DOI: 10.1097/PCC.0000000000003870
Raul Copana-Olmos, Nils Casson, Willmer Diaz-Villalobos, Victor Urquieta-Clavel, Mary Tejerina-Ortiz, Miguel Cespedes-Lesczinsky, Vladimir Aguilera-Avendaño, Maricruz Fernández-Vidal, Mariel Forest-Yepez, Danny Blanco-Espejo, Ibeth Rivera-Murguia, Claudia Castro-Auza, Milenka Gamboa-Lanza, Jhovana E Paco-Barral, Gustavo Choque-Osco, Betzhi Vera-Dorado, Carol Mendoza-Montoya, Magbely Cuellar-Gutierrez, Jaime Fernandez-Sarmiento

Objectives: In a cohort of children with septic shock, we evaluated the association between vasoactive agent use within 1 hour of starting our sepsis bundle and mortality. Secondarily, we assessed the relationship between sepsis bundle adherence and mortality and other outcomes.

Design: Nonpreplanned, secondary analysis of a national multicenter dataset collected in a resource-limited setting.

Setting: Dataset from 14 centers in Bolivia collected between January 2023 and December 2023.

Patients: Children under 15 years old with sepsis or septic shock defined using altitude-adjusted Phoenix criteria.

Interventions: None.

Measurements and main results: We included 268 patients in this secondary analysis, with median (interquartile range [IQR]) age 17 months (IQR, 6-63 mo). The sepsis bundle was used within 3 hours in 131 of 268 patients (49%). Vasopressors were used in 102 of 268 patients (38%) and 85 of 102 (83%) had received peripheral administration within the 1 hour of persistent hypotension, without any record of adverse events. Early vasopressor use within 1 hour of septic shock recognition, and antibiotic administration within 1 hour of sepsis recognition, were independently associated with lower odds (using adjusted odds ratio [aOR] and 95% CI) of mortality, respectively: 0.49 (95% CI, 0.28-0.89) and 0.41 (95% CI, 0.24-0.71; both p = 0.001). Failure to complete the sepsis bundle within 3 hours was associated with greater odds of mortality (aOR, 3.61 [95% CI, 1.64-7.91]; p = 0.001) and greater odds of longer interval before emergency consultation (aOR, 1.04 [95% CI, 1.01-1.07]; p = 0.023).

Conclusions: Early initiation of vasoactive agents in children with septic shock and timely sepsis bundle completion were independently associated with lower hazard of mortality. Historically, in Bolivia in 2023, bundle adherence was suboptimal, yet feasible interventions were associated with greater odds of better outcomes in pediatric sepsis and septic shock.

目的:在一组感染性休克儿童中,我们评估了开始脓毒症治疗后1小时内血管活性药物使用与死亡率之间的关系。其次,我们评估了脓毒症捆绑治疗依从性与死亡率和其他结果之间的关系。设计:对在资源有限的情况下收集的国家多中心数据集进行非预先计划的二次分析。数据集来自玻利维亚14个中心,收集时间为2023年1月至2023年12月。患者:15岁以下脓毒症或感染性休克的儿童,采用海拔调整凤凰标准。干预措施:没有。测量和主要结果:我们纳入了268例患者,中位年龄(四分位间距[IQR])为17个月(IQR, 6-63个月)。268例患者中有131例(49%)在3小时内使用了脓毒症包。268例患者中有102例(38%)使用血管加压药,102例患者中有85例(83%)在持续低血压1小时内接受外周给药,无任何不良事件记录。在脓毒症休克识别后1小时内早期使用血管加压素,以及在脓毒症识别后1小时内使用抗生素,与较低的死亡率(使用校正优势比[aOR]和95% CI)独立相关,分别为0.49 (95% CI, 0.28-0.89)和0.41 (95% CI, 0.24-0.71,均p = 0.001)。未能在3小时内完成脓毒症治疗与更高的死亡率相关(aOR, 3.61 [95% CI, 1.64-7.91]; p = 0.001),与更长的急诊会诊间隔时间相关(aOR, 1.04 [95% CI, 1.01-1.07]; p = 0.023)。结论:脓毒性休克患儿早期使用血管活性药物和及时完成脓毒症治疗与较低的死亡率独立相关。从历史上看,在2023年的玻利维亚,捆绑治疗依从性不是最佳的,但可行的干预措施与儿童败血症和感染性休克的更好结果的可能性较大相关。
{"title":"Sepsis Bundle Adherence and Early Vasopressor Administration in Pediatric Septic Shock: Secondary Analysis of Outcomes in a 2023 Multicenter Cohort in Bolivia.","authors":"Raul Copana-Olmos, Nils Casson, Willmer Diaz-Villalobos, Victor Urquieta-Clavel, Mary Tejerina-Ortiz, Miguel Cespedes-Lesczinsky, Vladimir Aguilera-Avendaño, Maricruz Fernández-Vidal, Mariel Forest-Yepez, Danny Blanco-Espejo, Ibeth Rivera-Murguia, Claudia Castro-Auza, Milenka Gamboa-Lanza, Jhovana E Paco-Barral, Gustavo Choque-Osco, Betzhi Vera-Dorado, Carol Mendoza-Montoya, Magbely Cuellar-Gutierrez, Jaime Fernandez-Sarmiento","doi":"10.1097/PCC.0000000000003870","DOIUrl":"10.1097/PCC.0000000000003870","url":null,"abstract":"<p><strong>Objectives: </strong>In a cohort of children with septic shock, we evaluated the association between vasoactive agent use within 1 hour of starting our sepsis bundle and mortality. Secondarily, we assessed the relationship between sepsis bundle adherence and mortality and other outcomes.</p><p><strong>Design: </strong>Nonpreplanned, secondary analysis of a national multicenter dataset collected in a resource-limited setting.</p><p><strong>Setting: </strong>Dataset from 14 centers in Bolivia collected between January 2023 and December 2023.</p><p><strong>Patients: </strong>Children under 15 years old with sepsis or septic shock defined using altitude-adjusted Phoenix criteria.</p><p><strong>Interventions: </strong>None.</p><p><strong>Measurements and main results: </strong>We included 268 patients in this secondary analysis, with median (interquartile range [IQR]) age 17 months (IQR, 6-63 mo). The sepsis bundle was used within 3 hours in 131 of 268 patients (49%). Vasopressors were used in 102 of 268 patients (38%) and 85 of 102 (83%) had received peripheral administration within the 1 hour of persistent hypotension, without any record of adverse events. Early vasopressor use within 1 hour of septic shock recognition, and antibiotic administration within 1 hour of sepsis recognition, were independently associated with lower odds (using adjusted odds ratio [aOR] and 95% CI) of mortality, respectively: 0.49 (95% CI, 0.28-0.89) and 0.41 (95% CI, 0.24-0.71; both p = 0.001). Failure to complete the sepsis bundle within 3 hours was associated with greater odds of mortality (aOR, 3.61 [95% CI, 1.64-7.91]; p = 0.001) and greater odds of longer interval before emergency consultation (aOR, 1.04 [95% CI, 1.01-1.07]; p = 0.023).</p><p><strong>Conclusions: </strong>Early initiation of vasoactive agents in children with septic shock and timely sepsis bundle completion were independently associated with lower hazard of mortality. Historically, in Bolivia in 2023, bundle adherence was suboptimal, yet feasible interventions were associated with greater odds of better outcomes in pediatric sepsis and septic shock.</p>","PeriodicalId":19760,"journal":{"name":"Pediatric Critical Care Medicine","volume":" ","pages":"137-145"},"PeriodicalIF":4.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pediatric Critical Care Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1